Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium

Saudi Medical Journal

Volumn 28, Issue 5, 2007, Pages 727-731

  Ocak, Sabahattin ^a   Cetin, Meryem ^a   Hakverdi, Sibel ^a   Dolapcioglu, Kenan ^b   Gungoren, Arif ^a   Hakverdi, Ali U ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b ANTAKYA STATE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ACTINOMYCES; ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EROSION; VAGINA DISCHARGE; VAGINA EPITHELIUM; VAGINA FLORA; VAGINITIS; EPITHELIUM; MICROBIOLOGY; VAGINA;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; EPITHELIUM; FEMALE; HUMANS; INTRAUTERINE DEVICES; VAGINA; VAGINOSIS, BACTERIAL;

EID: 34547426344     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wahwire-Mangen F et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 546-550.
2. 2-producing Lactobacilli and vaginal E. coli colonization in women with recurrent UTI. J Infect Dis 1998; 178: 446-450.
3. Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P et al. Hydrogen peroxide-producing Lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-1063.
4. Hooton TM, Roberts PL, Stamm WE. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994; 19: 274-278.
5. Tosun I, Aydin F, Kaklikkaya N, Yazici Y, Frequency of bacterial vaginosis among women attending for intrauterine device insertion at an inner-city family planning clinic. Eur J Contracept Reprod Health Care 2003; 8: 135-138.
6. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992; 339: 785-788.
7. Caliskan E, Ozturk N, Dilbaz BO, Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003; 8: 150-155.
8. Burkman RT. Intrauterine devices and pelvic inflammatory disease: evolving perspectives on the data. Obstet Gynecol Surv 1996; 51: 35-40.
9. Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: A prospective study. Sex Transm Dis 1990; 17: 23-29.
10. Calzolari E, Masciangelob R, Militea V, Verteramoa R. Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 2000; 70: 341-346.
11. Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE. Effects of contraceptive method on the vaginal microbial flora: A prospective evaluation. J Infect Dis 2000; 181: 595-597.
12. Krishna A, Usha S, Vena A. Microbial and cytopathological study of intrauterine contraceptive device users Indian. J Med Sci 2004; 58: 394-399.
13. Kazerooni T, Mosalaeeb A. Does contraceptive method change the Pap smear finding? Contraception 2002; 66: 243-246.
14. Briton LA. Oral contraceptive and cervical neoplasia. Contraception 1991; 43: 581-595.
15. Eschenbach DA, Patton DL, Meier A, Thwin SS, Aura J, Stapleton A et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception 2000; 62: 107-112.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
17. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physician 2003; 68: 1992-1998.
18. Ferraz do Lago R, Simoes JA, Bahamondes L, Camargo RP, Perrotti M, Monteiro I. Follow-up of users of intrauterine device with and without bacterial vaginosis and other cerviconvaginal infections. Contraception 2003; 68: 105-109.
19. Beerthuizen RJ. Pelvic inflammatory disease in intrauterine device users. Eur J Contracept Reprod Health Care 1996; 1: 237-243.
20. Joesoef MR, Karundeng A, Runtupalit C, Moran JS, Lewis JS, Ryan CA. High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception 2001; 64: 169-162.
21. Eschenbach DA, Patton DL, Meier A, Thwin SS, Aura J, Stapleton A, et al. Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis 2001; 183: 913-918.
22. Linhares LM, Witkin SS, Miranda SD, Fonseca AM, Pinotti JA, Ledger WJ. Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Infect Dis Obstet Gynecol 2001; 9: 221-225.
23. Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvo-vaginal candidiasis. Contraception 1995; 51: 293-297.
24. Nayar M, Chandra M, Chitraratha K, Kumari Das S, Rai Chowdhary G. Incidence of actinomycetes infection in women using intrauterine contraceptive devices. Acta Cytol 1985; 29: 111-116.
25. Hatch KD, Hacker NF. Intraepithelial disease of the cervix, vagina and vulva. In: Berek JS, editors. Novak's gynecology. Baltimore, Maryland: Williams & Wilkins; 1996; 447-486.
26. Kaplan B, Orvieto R, Hirsch M, Rabinerson D, Braslavski D. Bar-Hava I et al. The impact of intrauterine contraceptive devices on cytological findings from routine Pap smear testing. Eur J Contracept Reprod Health Care 1998; 3: 75-77.
27. Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 1990; 163: 510-514.
28. Demirezen S. Trichomonas vaginalis in vaginal smears of women using intrauterine contraceptive device. Cent Eur J Public Health 2001; 9: 176-178.
29. Pillay B, Gregory AR, Subbiah M. Cytopathologic changes associated with intrauterine contraceptive devices. A review of cervico-vaginal smears in 350 women. Med J Malaysia 1994; 49: 74-77.
30. Belkahla N, Ourak S, Ouerghi H, Kchir N, Mrad I, Oueslati H et al. Abdomino-pelvic actinomycosis. Report of 2 cases. Tunis Med 2004; 82: 772-776.